cTnI, a contractile protein unique to the heart muscle, is a sensitive biomarker, which was introduced predominantly for risk stratification in patients exhibiting acute coronary syndrome and is the gold standard for identifying MI (18,19); in addition, ACE2 is expressed in the heart and has been observed to exhibit a protective effect during MI (8–11). The gene discussed is ACE2; the disease is acute coronary syndrome.